Skip to main content
SpringerLink
Log in

Medikamentöse Therapie während der Schwangerschaft

Medication therapy during pregnancy

  • CME Zertifizierte Fortbildung
  • Published:
HNO Aims and scope Submit manuscript

Zusammenfassung

Während der Schwangerschaft nehmen etwa 85% aller Frauen mindestens ein Medikament ein. Dabei sind etwa 1% aller schwerwiegenden Fehlbildungen auf die Einnahme von embryotoxischen Medikamenten zurückzuführen. Da sowohl der HNO-Arzt als auch die Schwangere bei der Gabe von Medikamenten häufig unsicher sind, erfolgt die Therapie von spezifischen HNO-Problemen oft durch Gynäkologen. Anhand einer ausführlichen Literaturrecherche und unter Berücksichtigung der Empfehlungen der Roten Liste® des Bundesverbands der Pharmazeutischen Industrie e. V. und der US-amerikanischen Food and Drug Administration (FDA) werden in diesem Fortbildungsartikel typische Hals-Nasen-Ohren-ärztliche Erkrankungen aufgeführt und mögliche medikamentöse Therapien erörtert.

Abstract

Approximately 85% of pregnant woman receive at least one medical prescription during their gestation. One percent of major congenital malformations of the fetus are attributed to embryotoxic medication. Because ENT surgeons and pregnant women are often uncertain about proper medication, treatment of specific ENT problems is often provided by the obstetrician. Based on the current knowledge, PubMed research, and recommendations of the Red List (Rote Liste) of the German Pharmaceutical Industry and the FDA, medical treatment of ENT-specific diseases is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Egen-Lappe V, Hasford J (2004) Drug prescription in pregnancy: analysis of a large statutory sickness fund population. Eur J Clin Pharmacol 60(9):659–666

    Article  PubMed  Google Scholar 

  2. Rubin PC, Craig GF, Gavin K, Sumner D (1986) Prospective survey of use of therapeutic drugs, alcohol, and cigarettes during pregnancy. Br Med J (Clin Res Ed) 292(6513):81–83

    Article  Google Scholar 

  3. Ash P, Vennart J, Carter CO (1977) The incidence of hereditary disease in man. J Med Genet 14:305

    Article  PubMed  CAS  Google Scholar 

  4. Vlastarakos PV, Nikolopoulos TP, Manolopoulos L et al (2008) Treating common ear problems in pregnancy: what is safe? Eur Arch Otorhinolaryngol 265(2):139–145

    Article  PubMed  Google Scholar 

  5. Rote Liste® (2011) Arzneimittel in Schwangerschaft und Stillzeit, Beratungsstellen. Rote Liste® Service GmbH, Frankfurt/Main, S 2171

  6. Gani Braida A, Lombardi C, Del Giudice A et al (2003) Rhinitis in pregnancy. Allerg Immunol (Paris) 35(8):306–313

    Google Scholar 

  7. Ellegard EK (2004) Clinical and pathogenetic characteristics of pregnancy rhinitis. Clin Rev Allergy Immunol 26(3):149–159

    Article  PubMed  Google Scholar 

  8. (o A) (2004) Gastroschisis and pseudoephedrine during pregnancy. Prescrire Int 13(72):141–143

  9. Werler MM (2006) Teratogen update: pseudoephedrine. Birth Defects Res A Clin Mol Teratol 76(6):445–452

    Article  PubMed  CAS  Google Scholar 

  10. Torfs CP, Katz EA, Bateson TF et al (1996) Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 54(2):84–92

    Article  PubMed  CAS  Google Scholar 

  11. Werler MM, Mitchell AA, Shapiro S (1992) First trimester maternal medication use in relation to gastroschisis. Teratology 45(4):361–367

    Article  PubMed  CAS  Google Scholar 

  12. Mazzotta P, Loebstein R, Koren G (1999) Treating allergic rhinitis in pregnancy. Safety considerations. Drug Saf 20(4):361–375

    Article  PubMed  CAS  Google Scholar 

  13. Gilbert C, Mazzotta P, Loebstein R, Koren G (2005) Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review. Drug Saf 28(8):707–719

    Article  PubMed  CAS  Google Scholar 

  14. Osur SL (2005) The management of asthma and rhinitis during pregnancy. J Womens Health (Larchmt) 14(3):263–276

    Article  Google Scholar 

  15. Källén BA, Otterblad Olausson P (2003) Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 17(3):255–261

    Article  PubMed  Google Scholar 

  16. Gluck PA, Gluck JC (2005) A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide. Curr Med Res Opin 21(7):1075–1084

    Article  PubMed  CAS  Google Scholar 

  17. Keles N (2004) Treatment of allergic rhinitis during pregnancy. Am J Rhinol 18(1):23–28

    PubMed  Google Scholar 

  18. Ostensen ME, Skomsvoll JF (2004) Anti-inflammatory pharmacotherapy during pregnancy. Expert Opin Pharmacother 5(3):571–580

    Article  PubMed  CAS  Google Scholar 

  19. Fardet L, Nizard J, Genereau T (2002) Non-selective and selective non-steroidal anti-inflammatory drugs, administration in pregnancy and breast feeding (article in French). Presse Med 31(31):1462–1468

    PubMed  Google Scholar 

  20. Burdan F, Belzek A (2001) Current opinions on embryotoxic and teratogenic effects of ibuprofen (article in Polish/abstract). Pol Merkur Lekarski 11(63):266–270

    PubMed  CAS  Google Scholar 

  21. Ostensen M (1998) Nonsteroidal anti-inflammatory drugs during pregnancy. Scand J Rheumatol Suppl 107:128–132

    PubMed  CAS  Google Scholar 

  22. Ramsey-Goldman R, Schilling E (1997) Immunosuppressive drug use during pregnancy. Rheum Dis Clin North Am 23(1):149–167

    Article  PubMed  CAS  Google Scholar 

  23. Adams BK, Cydulka RK (2003) Asthma evaluation and management. Emerg Med Clin North Am 21(2):315–330

    Article  PubMed  Google Scholar 

  24. Dombrowski MP (1997) Pharmacologic therapy of asthma during pregnancy. Obstet Gynecol Clin North Am 24(3):559–574

    Article  PubMed  CAS  Google Scholar 

  25. Lockshin MD, Sammaritano LR (1998) Corticosteroids during pregnancy. Scand J Rheumatol Suppl 107:136–138

    PubMed  CAS  Google Scholar 

  26. Haas A, Maschmeyer G (2008) Antibiotikatherapie in der Schwangerschaft. Dtsch Med Wochenschr 133:511–515

    Article  PubMed  CAS  Google Scholar 

  27. Shehata H, Nelson-Piercy C (2001) Drugs to avoid. Best Pract Res Clin Obstet Gynaecol 15(6):971–986

    Article  PubMed  CAS  Google Scholar 

  28. Briggs GG (1998) Tetracycline: effect on fetal bone growth. J Am Pharm Assoc 38(6):717–727

    CAS  Google Scholar 

  29. Rote Liste® (2012) Aciclovir. http://www.rote-liste.de/

  30. Haddad J, Messer J, Willard D, Ritter J (1989) Acyclovir and pregnancy: current aspects (article in French). J Gynecol Obstet Biol Reprod (Paris) 18(5):679–683

    Google Scholar 

  31. Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V. (2010) Leitlinie „ Hörsturz (Akuter idiopathischer sensorineuraler Hörverlust)“. AWMF online. http://www.awmf.org/leitlinien. Zugegriffen: 22.03.12

  32. Hellebrand MC, Friebe-Hoffmann U, Bender HG et al (2006) Mona Lisa syndrome: idiopathic facial paralysis during pregnancy. Z Geburtshilfe Neonatol 210(4):126–134

    Article  PubMed  Google Scholar 

  33. Leathem AM (1986) Safety and efficacy of antiemetics used to treat nausea and vomiting in pregnancy. Clin Pharm 5(8):660–668

    PubMed  CAS  Google Scholar 

  34. Schroder O, Stein J (2002) Vomiting in pregnancy. When is it more than only a bothersome nuisance? (article in German). MMW Fortschr Med 144(50):32–34

    PubMed  CAS  Google Scholar 

  35. Cohen-Kerem R, Railton C, Oren D et al (2005) Pregnancy outcome following non-obstetric surgical intervention. Am J Surg 190(3):467–473

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Die korrespondierende Autorin gibt für sich und ihren Koautor an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Hals-Nasen-Ohrenklinik, Lukaskrankenhaus Neuss GmbH, Preußenstr. 84, 41464, Neuss, Deutschland

    S. Gronau & A. Neumann

Authors
  1. S. Gronau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Neumann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Gronau.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gronau, S., Neumann, A. Medikamentöse Therapie während der Schwangerschaft. HNO 60, 637–650 (2012). https://doi.org/10.1007/s00106-012-2517-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00106-012-2517-y

Schlüsselwörter

Keywords

Search

Navigation